European Journal of Cancer
Volume 39, Issue 3 , Pages 372-377 , February 2003

Does use of alternative medicine predict survival from cancer?

  • T Risberg

      Affiliations

    • Department of Oncology, University Hospital of Tromsø, Tromsø, Norway
    • Corresponding Author InformationCorresponding author. Tel.: +47-1147-77626000; fax: +47-1147-77626779
    • ,
  • A Vickers

      Affiliations

    • Integrative Medicine Service, Biostatistics Service, Memorial Sloan-Kettering Cancer Center, New York 10021, USA
    • ,
  • R.M Bremnes

      Affiliations

    • Department of Oncology, University Hospital of Tromsø, Tromsø, Norway
    • ,
  • E.A Wist

      Affiliations

    • Department of Oncology, Ulleval University Hospital, Oslo, Norway
    • ,
  • S Kaasa

      Affiliations

    • Palliative Medicine Unit. Department of Oncology, University Hospital of Trondheim, Trondheim, Norway
    • ,
  • B.R Cassileth

      Affiliations

    • Integrative Medicine Service, Memorial Sloan-Kettering Cancer Center, New York 10021, USA

Received 27 May 2002 ,Revised 25 September 2002 ,Accepted 30 October 2002.

References 

  1. Astin JA. Why patients use alternative medicine (results of a national study). JAMA. 1998;279:1548–1553
  2. Lerner IJ. The whys of cancer quackery. Cancer. 1984;538(Suppl. 3):15–19
  3. Cassileth BR, Chapman CC. Alternative and complementary cancer therapies. Cancer. 1996;77:1026–1034
  4. van der Zouwe N, van Dam FS, Aaronson NK, Hanewald GJ. Alternative treatments in cancer; extent and background of utilization. Ned Tijdschr Geneeskd. 1994;138:300–306
  5. Stoll BA. Can unorthodox cancer therapy improve quality-of-life?. Ann. Oncol. 1993;4:121–123
  6. Risberg T, Kaasa S, Wist E, Melsom H. Why are cancer patients using non-proven complementary therapies? A cross-sectional multicentre study in Norway. Eur. J. Cancer. 1997;33:575–580
  7. Downer SM, Cody MM, McCluskey P, et al.  Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ. 1994;309:86–89
  8. Davidson JR, Rampes H, Eisen M, Fisher P, Smith RD, Malik M. Psychiatric disorders in primary care patients receiving complementary medical treatments. Compr. Psychiatry. 1998;39:16–20
  9. Burstein HJ, Gelber S, Guadagnoli E, Weeks JC. Use of alternative medicine by women with early-stage breast cancer. N. Engl. J. Med. 1999;340:1733–1739
  10. Carlsson M, Arman M, Backman M, Hamrin E. Perceived quality of life and coping for Swedish women with breast cancer who choose complementary medicine. Cancer Nurs. 2001;24:395–401
  11. Sollner W, Maislinger S, DeVries A, Steixner E, Rumpold G, Lukas P. Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior (a survey). Cancer. 2000;89:873–880
  12. Risberg T, Lund E, Wist E, Kaasa S, Wilsgaard T. Cancer patients use of nonproven therapy (a 5-year follow-up study). J. Clin. Oncol. 1998;16:6–12
  13. Risberg T, Lund E, Wist E, Dahl O, Sundstrom S, Andersen OK, et al.  The use of non-proven therapy among patients treated in Norwegian oncological departments. A cross-sectional national multicentre study. Eur. J. Cancer. 1995;31A:1785–1789
  14. Andrews FM, Withey SB. Social Indicatior of Well-Being. Americans' Perceptions of Life Quality. New York: Plenum Press; 1976;
  15. Holmen J, Midthjell K, Bjartveit K, et al. The North-Trondelag Health Survey 1984–1986. Purpose, Background and Methods. Participation, Non-Participation and Frequency Distributions, Vol. 4. Verdal, Norway: National Institute of Public Health, Community Medicine Research Centre 1990.
  16. Stein Kaasa, Arne Masterkaasa, Eilif Lund. Prognostic factors for patients with inoperable non-small cell lunge cancer, limited disease. The importance of patients' subjective experience of disease and psychosocial well-being. Radiother Oncol 1989, 15, 235–242.
  17. Risberg T, Lund E, Wist E. Use of non-proven therapies. Differences in attitudes between Norwegian patients with non-malignant disease and patients suffering from cancer. Acta Oncol. 1995;34:893–898
  18. Cassileth BR, Lusk EJ, Strouse TB, Bodenheimer BJ. Contemporary unorthodox treatments in cancer medicine. A study of patients, treatments, and practitioners. Ann. Intern. Med. 1984;101:105–112
  19. Coates A, Porzsolt F, Osoba D. Quality of life in oncology practice (prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy). Eur. J. Cancer. 1997;33:1025–1030
  20. Chang VT, Thaler HT, Polyak TA, Kornblith AB, Lepore JM, Portenoy RK. Quality of life and survival (the role of multidimensional symptom assessment). Cancer. 1998;83:173–179
  21. Ganz PA, Lee JJ, Siau J. Quality of life assessment. An independent prognostic variable for survival in lung cancer. Cancer. 1991;67:3131–3135

PII: S0959-8049(02)00701-3

European Journal of Cancer
Volume 39, Issue 3 , Pages 372-377 , February 2003

Article Tools

* Image Usage & Resolution